等待开盘 06-26 09:30:00 美东时间
0.000
0.00%
New On The Block Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, announced that, after extensive consideration of the company's pipeline and financial resources, it has retained Raymond James as its financial advisor to assist in evaluating a full range of strategic alternative...
06-13 02:40
Chiesi completes acquisition of KalVista for $27 a share Chiesi Group completed its acquisition of KalVista Pharmaceuticals on June 11, 2026. Chiesi’s tender offer paid USD 27 per share in cash, taking about 77.8% of outstanding shares. A follow-on merger cancelled remaining shares, converting them
06-11 20:41
KalVista Pharmaceuticals周四在2026年国际药物经济学与结果研究学会年会及东部过敏会议上公布的新数据显示,针对2至11岁遗传性血管性...
05-28 23:16
"These data highlight the significant unmet needs that exist for children living with HAE and the families who care for them," said Ben Palleiko, Chief Executive Officer of KalVista. "Currently, the only FDA-approved
05-28 19:12
DRI HEALTHCARE TRUST (TSX:DHT) held its first-quarter earnings conference call ...
05-15 21:47
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
05-15 05:22
随着4月结束,市值20亿美元以下的小型医疗保健股空头头寸显著增加,显示市场对这类高波动性股票的看空情绪升温。 根据最新数据,5月初医疗保健板块空头比例最...
05-05 03:24
累计净回报超2600%!资管公司潘兴广场上市三日累涨超58%;慧荣科技周涨超52%,Q1营收同比翻倍大超预期>>
05-04 18:33
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
Needham analyst Serge Belanger downgrades KalVista Pharmaceuticals (NASDAQ:KALV) from Buy to Hold.
05-01 02:02